We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

94 hedge funds and large institutions have $589M invested in Epizyme, Inc in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more capital invested

Capital invested by funds: $450M → $589M (+$139M)

19% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 27

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% less call options, than puts

Call options by funds: $1.09M | Put options by funds: $1.09M

3% less funds holding

Funds holding: 97 → 94 (-3)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

Holders
94
Holders Change
-3
Holders Change %
-3.09%
% of All Funds
2.35%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
9
Increased
32
Reduced
27
Closed
11
Calls
$1.09M
Puts
$1.09M
Net Calls
-$5K
Net Calls Change
+$842K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$13.7M
2
GTC
Ghost Tree Capital
New York
+$4.96M
3
State Street
State Street
Massachusetts
+$3.76M
4
PAI
Palo Alto Investors
California
+$2.31M
5
BFA
BlackRock Fund Advisors
California
+$2.26M

Top Sellers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
-$3.34M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.77M
3
SCA
Secor Capital Advisors
New York
-$1.67M
4
IHM
Iguana Healthcare Management
New York
-$1.48M
5
Millennium Management
Millennium Management
New York
-$1.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baker Bros. Advisors
New York
$2.81M – – –
JP Morgan Chase
27
JP Morgan Chase
New York
$2.53M -$159K -15,200 -7%
CS
28
Candriam SCA
Luxembourg
$2.53M +$261K +25,000 +14%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.2M +$167K +16,040 +10%
CAM
30
Cormorant Asset Management
Massachusetts
$1.93M – – –
JGC
31
J. Goldman & Co
New York
$1.88M +$783K +75,049 +94%
BIM
32
BlackRock Investment Management
Delaware
$1.85M -$4.51K -432 -0.3%
Deutsche Bank
33
Deutsche Bank
Germany
$1.84M -$759K -72,692 -32%
Millennium Management
34
Millennium Management
New York
$1.75M -$1.35M -129,791 -47%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$1.68M -$73.1K -7,000 -5%
Charles Schwab
36
Charles Schwab
California
$1.56M +$67.5K +6,468 +5%
Morgan Stanley
37
Morgan Stanley
New York
$1.53M -$1.35M -129,196 -50%
TCIM
38
TIAA CREF Investment Management
New York
$1.39M -$130K -12,467 -10%
QI
39
QS Investors
New York
$1.14M – – –
Principal Financial Group
40
Principal Financial Group
Iowa
$1.13M +$39K +3,734 +4%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$1M -$23K -2,200 -3%
TA
42
Teachers Advisors
New York
$821K – – –
Swiss National Bank
43
Swiss National Bank
Switzerland
$807K +$106K +10,200 +18%
EIM
44
Essex Investment Management
Massachusetts
$723K +$624K +59,776 New
AA
45
ALPS Advisors
Colorado
$675K -$189K -18,138 -25%
PP
46
PDT Partners
New York
$661K -$11.5K -1,100 -2%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$658K +$568K +54,373 New
Goldman Sachs
48
Goldman Sachs
New York
$646K +$314K +30,061 +129%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$574K +$53.2K +5,096 +12%
NFA
50
Nationwide Fund Advisors
Ohio
$543K -$13.3K -1,278 -3%
1
2
3 4 5

EPZM Hedge Fund Activity: Q4 2016 in Review

94 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2016, worth a combined $589M — up 31% from $450M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of EPZM and 9 opened new positions — a net loss of 2 holders — while 27 trimmed existing stakes and 32 added.

The largest buyer was Deerfield Management, adding an estimated $13.7M. The largest seller was QVT Financial, cutting an estimated $3.34M.

  • 94 institutional investors held Epizyme, Inc (EPZM) as of Q4 2016, down from 97 in Q3 2016.
  • Funds reported $589M of Epizyme, Inc stock for Q4 2016, up 31% quarter-over-quarter.
  • 9 funds opened new Epizyme, Inc positions in Q4 2016 and 11 closed out, a net change of -2 holders.
  • The largest Epizyme, Inc buyer in Q4 2016 was Deerfield Management, an estimated $13.7M added.
  • The largest Epizyme, Inc seller in Q4 2016 was QVT Financial, an estimated $3.34M sold.

Based on aggregated 13F filings for Q4 2016.